517% GAIN ON THIS ARORA MARIJUANA PORTFOLIO COMPANY
By Nigam Arora & Dr. Natasha Arora
517% Gain
Congratulations! Arena Pharmaceuticals (ARNA), a biotech associated with marijuana, has received a $100 per share all-cash offer from Pfizer (PFE). ARNA is long from the original Arora buy signal from $16.20. At a $100 cash offer, it represents a gain of 517%.
Arena has been in the Arora MARIJUANA MODEL PORTFOLIO. We have repeatedly flagged for our subscribers that ARNA was a buyout candidate and that was one of the reasons to buy the stock. That call has now proven spot on.
To date, 169 of Arora portfolio companies have been bought out producing a fortune for long-time subscribers.… Please click here or the title below to read more.
December 14, 2021